Propanc Biopharma Inc.

PPCB | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.92

+$0.08 (+4.35%)

Nov 2, 2026, 10:34 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2026 Jun 30, 2026	FY 2025 Jun 30, 2025	FY 2024 Jun 30, 2024	FY 2023 Jun 30, 2023	FY 2022 Jun 30, 2022	FY 2021 Jun 30, 2021
Cash & Equivalents	832.01K	12.09K	21.09K	10.05K	4.07K	2.26K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	4.19M	11.22M	29.13K	2K	2.08K	2.25K
Receivables	13.69K	5.3K	2.95K	2.87K	2.34K	4.34K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	7.7M	1.38K	1.41K	n/a	n/a	n/a
Total Current Assets	8.54M	8.35M	25.44K	19.04K	15.03K	6.6K
Property-Plant & Equipment	44.71K	59.41K	17.8K	39.29K	64.55K	4.26K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	4.24M	11.28M	46.92K	41.29K	66.62K	6.51K
Total Assets	12.78M	19.63M	72.37K	60.33K	81.65K	13.1K
Account Payables	1.13M	1.25M	1.21M	966.72K	943.02K	1M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	24.49K	1.56M	870.27K	505.13K	977.61K	680.08K
Other Current Liabilities	2.2M	1.07M	773.26K	1.01M	567.06K	472.76K
Total Current Liabilities	3.35M	5.58M	3.79M	3.16M	3.06M	3.08M
Long-Term Debt	23.82K	105.63K	58.64K	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	23.82K	147.38K	58.64K	19.28K	42.32K	n/a
Total Liabilities	3.38M	5.73M	3.85M	3.18M	3.11M	3.08M
Total Debt	48.31K	1.73M	948.27K	545.92K	1.04M	680.08K
Book Value	9.4M	13.91M	-3.78M	-3.12M	-3.02M	-3.07M
Book Value Per Share	83.67	876.09	-0.04	-26.89M	-664.84M	-15.17B
Common Stock	3.8K	11.62K	478.8K	7.65K	240	14.06K
Retained Earnings	-144.48M	-125.62M	-66.7M	-64.68M	-61.56M	-58.2M
Comprehensive Income	1.18M	1.32M	1.27M	1.29M	1.23M	1.09M
Shareholders Equity	9.4M	13.91M	-3.78M	-3.12M	-3.02M	-3.07M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a